According to filings with the U.S. Securities and Exchange Commission, Salus Scientific is raising up to $8,019,192.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Salus Scientific
At Salus Scientific, our mission is personal. Founded by healthcare providers for healthcare providers, we are driven by a deep commitment to protect those who care for others. Our journey began when one of our founding physicians designed the first GLiFT system to relieve chronic pain from a personal injuryan innovation that not only allowed him to continue practicing but also inspired a broader vision: to serve his peers and improve their safety, comfort, and longevity in the field. As an emerging leader in advanced radiation protection, were not just creating productswere solving real problems. Were eliminating the hidden occupational hazards that have too long been accepted as part of the job. Through innovation, education, and a deep understanding of the industry, were changing how safety is delivered in the fluoroscopy suite.

To learn more about Salus Scientific, visit https://www.salusscientific.com/
Salus Scientific Linkedin Page: https://www.linkedin.com/company/salus-scientific-corp/

Contact:
Jon Wallace, Officer General Counsel
843-367-5187
https://www.linkedin.com/in/jon-wallace-6b7a044b/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.